M.P. AYYAPPANKUTTY vs STATE OF KERALA .

The Supreme Court addressed the issue of the quality of anti-rabies vaccine supplied by the Human Biological Institute, which was found to be sub-standard as per reports from the Central Drugs Laboratory. The Court held that the State Government's decision to award the tender was justified based on the quality of the vaccine, and that there was no evidence linking the vaccine to the death of a patient, as the cause was determined to be clinical rabies. The appeal against the High Court's dismissal of the writ petition was therefore rejected, affirming the State's actions regarding the tender process.